Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma

Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal... RESEARCH ARTICLE Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma Dae-Woon Eom, MD, PhD,* Seung-Mo Hong, MD, PhD,w Gwangil Kim, MD, PhD,z Young Kyung Bae, MD, PhD,y Kee-Taek Jang, MD, PhD,8 and Eunsil Yu, MD, PhDw rimary small intestinal adenocarcinoma (SIAC) is an Background: Small intestinal adenocarcinoma (SIAC) is a rare Pextremely rare tumor, although the small intestine human malignant tumor. According to the cancer stem cell accounts for one of the largest surface areas in the human (CSC) hypothesis, only a small subpopulation of tumor cells has body, occupying about 90% of the absorptive surface the ability to initiate and increase tumor growth. CD44v6, area of the gastrointestinal tract. Despite recent advances CD133, CD166, and ALDH1 have been proposed to be putative in endoscopic modalities and imaging techniques for ap- CSC markers in gastrointestinal malignancies. However, their proaching the small intestine, early detection of SIACs is implications in SIAC still remain unclear. We aimed to inves- quite difficult and the 5-year survival rate of SIACs di- tigate the expressions of CD44v6, CD133, CD166, and ALDH1 1 agnosed in the advanced disease state is 41.2%. There is and evaluate their relationships with clinicopathologic para- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma

Applied Immunohistochemistry & Molecular Morphology , Volume Publish Ahead of Print – Feb 1, 2015

Loading next page...
 
/lp/wolters-kluwer-health/prognostic-significance-of-cd44v6-cd133-cd166-and-aldh1-expression-in-Ya7FUjq500

References (32)

Copyright
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1541-2016
DOI
10.1097/PAI.0000000000000140
pmid
25710579
Publisher site
See Article on Publisher Site

Abstract

RESEARCH ARTICLE Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma Dae-Woon Eom, MD, PhD,* Seung-Mo Hong, MD, PhD,w Gwangil Kim, MD, PhD,z Young Kyung Bae, MD, PhD,y Kee-Taek Jang, MD, PhD,8 and Eunsil Yu, MD, PhDw rimary small intestinal adenocarcinoma (SIAC) is an Background: Small intestinal adenocarcinoma (SIAC) is a rare Pextremely rare tumor, although the small intestine human malignant tumor. According to the cancer stem cell accounts for one of the largest surface areas in the human (CSC) hypothesis, only a small subpopulation of tumor cells has body, occupying about 90% of the absorptive surface the ability to initiate and increase tumor growth. CD44v6, area of the gastrointestinal tract. Despite recent advances CD133, CD166, and ALDH1 have been proposed to be putative in endoscopic modalities and imaging techniques for ap- CSC markers in gastrointestinal malignancies. However, their proaching the small intestine, early detection of SIACs is implications in SIAC still remain unclear. We aimed to inves- quite difficult and the 5-year survival rate of SIACs di- tigate the expressions of CD44v6, CD133, CD166, and ALDH1 1 agnosed in the advanced disease state is 41.2%. There is and evaluate their relationships with clinicopathologic para-

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: Feb 1, 2015

There are no references for this article.